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The objective of this thesis was to evaluate the blood and milk concentrations of  
lipopolysaccharide-binding protein (LBP) from cows with naturally-occurring mastitis as 
biomarkers of this disease.  Milk and blood samples were collected from 101 clinically 
healthy dairy cows and 17 dairy cows with clinical mastitis.  The concentrations of LBP, 
haptoglobin and serum amyloid A (SAA) were determined in these samples by enzyme-
linked immunosorbent assay.  Both LBP and haptoglobin concentrations were higher in 
the milk and blood of quarters and cows with clinical mastitis respectively than in those 
that were healthy.  Whereas haptoglobin concentrations differed between uninfected and 
subclinically-infected quarters, LBP concentrations only differed between them when 
milk somatic cell counts were low. Unlike haptoglobin and SAA, blood concentrations of 
LBP in cows with a subclinical intramammary infection were not significant from those 
of cows with all healthy quarters. Thus, haptoglobin may be a preferred biomarker of 
subclinical intramammary infection.  
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Chapter 1: Literature Review 
1.1 Introduction 
Mastitis is one of the most costly and prevalent diseases affecting the dairy industry 
(Wells et al., 1998; Wellenberg et al., 2002).  It is an inflammatory disease in the 
mammary gland, which is most commonly caused by bacterial infections.  Depending on 
the degree of inflammation, intramammary infections can be classified as either 
subclinical or clinical type.  Subclinical intramammary infections are more difficult to 
detect due to the absence of visible changes in the appearance of the milk or udder, while 
clinical infections are more readily detected by visual abnormalities in the milk and/or the 
presence of heat, pain and swelling in the infected gland (Bramley and Dodd, 1984; Sears 
and McCarthy, 2003a). 
 Clinical mastitis is accompanied by a large influx of blood leukocytes into the 
inflamed mammary gland, thereby, resulting in an increase in the milk somatic cell count 
(SCC) (Paape et al., 2003).  Clinical mastitis is also commonly characterized by increased 
vascular permeability and breakdown of the blood-milk barrier, which leads to the 
dysregulated influx into milk of such blood components as albumin and cations (Guidry 
et al., 1983).  Therefore, changes in milk SCC, bovine serum albumin (BSA), and 
electrical conductivity have all been used to assess the health status of the mammary 
gland.  Relative to clinical mastitis, changes in these parameters during subclinical 
intramammary infection are often more subtle and their degrees of effectiveness at 
identifying these infections have been reported to vary (Verhoeff and Smith, 1981; 
Sheldrake et al., 1983b; Fernando et al., 1985; Mattila et al., 1986). 
 In response to infection or inflammation, a rapid and non-specific reaction known 
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as the acute phase response (APR) is generally elicited by the host (Suffredini et al., 
1999).  The APR is characterized by changes in concentrations of a large number of 
plasma proteins, termed acute phase proteins (APP’s), which are produced predominantly 
by the liver (Pannen and Robotham, 1995).  In cows with experimentally-induced and 
naturally-occurring mastitis, haptoglobin and serum amyloid A (SAA) concentrations 
have been shown to increase in both blood and milk, thus, serving as indicators of the 
inflammatory status of the udder (Eckersall et al., 2001; Ohtsuka et al., 2001; Pedersen et 
al., 2003).  Correspondingly, both have been evaluated as biomarkers of intramammary 
infection and disease severity in cows with mastitis (Eckersall et al., 2001; Nielsen et al., 
2004; Gronlund et al., 2005; Hiss et al., 2007). 
 Another APP that is upregulated during experimentally-induced mastitis in cows 
is lipopolysaccharide-binding protein (LBP).  LBP is a 58 – 60 kDa protein that catalyzes 
the transfer of bacterial lipopolysaccharide, a highly pro-inflammatory component of the 
outer wall of Gram-negative bacteria, to CD14 (Tobias et al., 1999; Schumann and Latz, 
2000).  CD14, which exists as both a soluble and cell surface receptor, facilitates LPS 
presentation to Toll-like receptor-4.  This, in turn, results in the activation of intracellular 
signaling pathways that promote the upregulation of pro-inflammatory cytokines and 
adhesion molecules, which are involved in the host innate immune response to invading 
pathogens.   In addition to bacterial lipopolysaccharide, LBP has been reported to 
facilitate host recognition of, and activation by, cell wall products of Gram-positive 
bacteria (Fan et al., 1999; Schroder et al., 2003).  Although detection of bacterial wall 
products is a key event in the activation of the innate immune response, excessive 
activation can lead to an overwhelming host response and the development of life-
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threatening septic shock (Dinarello, 1997).  Data from several studies suggest that LBP 
may also aid in the detoxification of bacterial wall products, thus, diminishing an 
excessive pro-inflammatory response that can be deleterious to the host (Wurfel et al., 
1994; Wurfel and Wright, 1995; Vreugdenhil et al., 2003). 
 LBP concentrations increase in the blood and milk of cows following LPS 
challenge (Bannerman et al., 2003) and in response to experimentally-induced 
intramammary infections by such pathogens as Escherichia coli, Klebsiella pneumoniae, 
Mycoplasma bovis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus 
aureus, and Streptococcus uberis (Bannerman et al., 2004a; Bannerman et al., 2004b; 
Bannerman et al., 2004c; Bannerman et al., 2005; Kauf et al., 2007).  In these studies, 
LBP increases in milk temporally coincided with those in blood and occurred during a 
period of increased mammary vascular permeability.   This finding suggests that the 
preponderance of LBP in milk during the APR to intramammary infection originates from 
leakage out of the blood vasculature.  Interestingly, during experimentally-induced 
mastitis following intramammary infusion of Escherichia coli, Mycoplasma bovis, or 
Pseudomonas aeruginosa, LBP increases in blood have been shown to increase earlier, 
and remain elevated longer than SAA (Bannerman et al., 2005; Kauf et al., 2007; 
Bannerman et al., 2008), which  indicates a good diagnostic value for LBP as a biomarker 
of underlying intramammary infection.  To date, there have been no published studies 
investigating the use of LBP as a biomarker of naturally-acquired mastitis.  Therefore, the 
objective of this thesis was to evaluate the blood and milk concentrations of LBP from 
cows with naturally-occurring subclinical intramammary infections and clinical mastitis, 
and to determine whether LBP concentrations could differentiate quarters or cows that 
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were subclinically infected from those that were healthy.    
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1.2 Review of Bovine Mastitis  
1.2.1 Bovine Mastitis  
Bovine mastitis remains as the disease causing the most economic losses in the 
dairy industry worldwide despite the extensive progress in optimizing control programs 
over the decades. Economic losses were estimated to be approximately $185 per cow per 
year in the U.S.A and about £175 in the U.K. These losses included reduced production, 
increased replacement costs, discarded milk, drug costs, veterinary fees, and labor costs 
(National Mastitis Council, 1996; Kossaibati, 2000). Due to the general agreement among 
consumers and processors that dairy products should be wholesome, nutritious, safe and 
produced from healthy cows, bovine mastitis has also become an issue of food safety and 
animal welfare (Klei et al., 1998; Wells et al., 1998; Boor, 2001; Oliver et al., 2005). 
Bovine mastitis is an inflammation of the mammary gland that often results from 
an intramammary infection (IMI) by a microorganism (Bramley and Dodd, 1984; Bradley, 
2002). More than 100 different microorganisms including bacteria, mycoplasma, yeasts 
and algae can cause mastitis, although the majority of cases are caused by bacteria (Watts, 
1988). 
1.2.2 Mastitis and Pathogens  
 Mastitis has been traditionally classified as contagious and environmental mastitis 
based on the primary reservoir of causative agent within cows that leads to subsequent 
infection (Blowey and Edmondson, 1995). Contagious mastitis is defined as IMI 
transmitted from cow to cow or quarter to quarter (Fox and Gay, 1993). Under this 
definition, Streptococcus agalactiae, Corynebacterium bovis, Mycoplasma sp. and 
Staphylococcus aureus are considered as contagious mastitis pathogens. The primary 
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reservoir for these pathogens is the infected udder, and infections are spread among cows 
or between quarters during the milking process by contaminated milking units (Bramley 
and Dodd, 1984). Whereas Streptococcus agalatiae responds well to the regular 
antibiotics therapy, no effective antibiotics are available for  Staphylococcus aureus 
(Nickerson and Owens, 1993; Keefe, 1997; Barkema et al., 2006). However, the total 
eradication of Strep. agalactiae from dairy herds and a markedly reduced incidence of 
Staph. aureus have become true in some well managed dairy farms after meticulously 
following effective control programs directed at preventing new infections including 
post-milking disinfection of teat ends, strict milking time hygiene, dry cow therapy, and 
culling (Dodd, 1983; Eberhart, 1986; Fox and Gay, 1993; Keefe, 1997; Sears and 
McCarthy, 2003b). Mycoplasma species are contagious mastitis pathogens whose 
prevalence have been  underestimated due to their long incubation periods before the 
onset of clinical signs, lack of clinical signs and long persistence after clinical signs 
(Jasper, 1981; Pfutzner and Sachse, 1996; Gonzalez and Wilson, 2003; Kauf et al., 2007). 
Among different Mycoplasma species that infect cattle, Mycoplasma bovis is the most 
common and might be the most pathogenic cause of mastitis (Pfutzner and Sachse, 1996; 
Nicholas and Ayling, 2003). For diagnosis of this disease, special bacteriological culture 
procedures are required and it takes 7-10 days of incubation to confirm a negative sample 
(National Mastitis Council, 1999). Corynebacterium bovis is a minor pathogen (Harmon 
and Langlois, 1986). Moderate inflammation and slight increase in SCC are associated 
with most infections by C. bovis (Ngatia et al., 1991; Djabri et al., 2002). 
Environmental mastitis are caused by pathogens which can be found in virtually 
any surface area of the cow or her surrounding (Collier et al., 1982; Dodd, 1983; Smith, 
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1983; Hogan and Larry Smith, 2003). For this reason, the chance of environmental 
mastitis pathogens transferring among cows or quarters is minimal compared with the 
constant environmental exposure. Environmental mastitis pathogens consist of Gram-
negative bacteria, including Escherichia, Klebsiella, Enterobacter, Serratia and 
Pseudomonas and some Gram positive bacteria including Streptococcus dysgalactiae, 
Streptococcus uberis, and Enterococci. Mastitis caused by Escherichia, Klebsiella, 
Enterobacter are also referred to as coliform mastitis and they are mainly responsible for 
the majority of peracute cases of clinical mastitis in a herd (Hogan and Larry Smith, 
2003). The complete elimination of environmental mastitis is never a realistic goal. 
However, it is possible to reduce them to an economically acceptable incidence by 
implementing comprehensive control methods aimed at both decreasing exposure of teat 
ends and increasing the host resistance to environmental pathogens, which can include 
improvements in housing, the use of inorganic bedding, effective vaccines, adequate 
supplementation with vitamins and trace minerals and pre-dipping in some herds 
(Bushnell, 1984; Smith et al., 1985; Burvenich et al., 2003; Hillerton and Berry, 2003). 
Although the above classification of pathogens reflects their different epidemiology 
in dairy herds and the possible effective control programs in control of them, mastitis 
should be treated as an evolving disease (Bradley, 2002).  For example, Streptococcus 
uberis, once considered to be an environmental pathogen, has been found to behave as 
contagious pathogens such as Staphylococcus. aureus and can spread between cows by 
surviving in mammary epithelial cells (Baseggio et al., 1997; Phuektes et al., 2001; 
Almeida and Oliver, 2006; Tamilselvam et al., 2006). Similarly, Escherichia coli, 
traditionally associated with a transient infection, can persist in the mammary glands 
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(Bramley and Dodd, 1984; Dogan et al., 2006).  
Historically, coagulase-negative species of staphylococci (CNS) were referred to as 
skin flora opportunists and minor pathogens of the mammary gland (Smith and Hogan, 
1995). CNS include a variety of species other than Staphylococcus aureus. The 
predominant species isolated in most herds are Staphylococcus chromogenes, 
Staphylococcus simulans and Staphylococcus. epidermidis, Staphylococcus hyicus, 
Staphylococcus hominis, and Staphylococcus xylosus may also be found (Timms and 
Schultz, 1987). CNS were thought to cause only a mild inflammation of the mammary 
gland with modest increases in somatic cell count (SCC), and were infrequently 
associated with clinical mastitis (Jarp, 1991; Smith and Hogan, 1995; Taponen et al., 
2006). In some countries, however, CNS have become the predominant pathogen in 
subclinical mastitis (Pitkala et al., 2004; Tenhagen et al., 2006). The CNS are also the 
primary cause of intramammary infection in heifers at calving (De Vliegher et al., 2003; 
Nagahata et al., 2006). Whether CNS contribute significantly to the somatic cell counts in 
milk is controversial, it might be species specific (Chaffer et al., 1999; De Vliegher et al., 
2003). With a tendency of decreasing the upper legal limit for SCC, the elevation in SCC 
caused by the CNS has become an important issue (Rainard et al., 1990). 
1.2.3 Clinical Mastitis and Subclinical Mastitis  
Clinical mastitis is characterized by clinically visible signs. Typical examples of 
these signs include flakes, clots or other gross alterations in the appearance of the milk, 
swelling and discoloration of the udder, increased temperature or pain of the quarter. In 
general, the degree of swelling, severity of pain and the abnormal appearance of the milk 
from the infected quarters are correlating with the severity of infection and can be used as 
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a reference for the course of treatment. Obviously, no special methods are needed to 
detect clinical mastitis. 
In contrast, subclinical mastitis often develops without any clinically visible signs. 
When quarter SCC is equal or above 200,000 cells/ml and bacteria are isolated in the 
absence of clinical signs, then the quarter is diagnosed as subclinical mastitis. 
Correspondingly, subclinical mastitis may remain undetected in routine veterinary 
inspection without monitoring milk SCC and performing bacterial examinations in labs.    
1.3 Diagnostics of Subclinical Mastitis   
1.3.1Bacterial Examination 
Milk samples obtained aseptically from healthy mammary glands should not 
contain any microorganisms. Isolation of the same organism from duplicate milk samples 
collected consecutively represents a positive diagnosis of infection (National mastitis 
council, 2004). However, bacteriological cultures can be negative when the concentration 
of udder pathogens in milk is below the detection limitation either because bacteria can 
be readily cleared off from the mammary gland (eg. E.coli) or they can invade epithelial 
cells (eg. S.aureus) while they are undetectable in milk secretions (Erskine et al., 1991; 
Keefe, 1997; Kerro Dego et al., 2002).  Also, the number of bacteria being shed at a 
given time point by infected animals is not stable, such as the cyclic shedding by 
S.aureus, multiple samples at different time points might be necessary under this 
condition. On the other hand, false positive results from contamination may occur 
considering that many common mastitis pathogens can be present everywhere in the 
environment. In addition, not all pathogens can be cultured on regular media and thereby 
general results from routine cultural procedures can only serve as preliminary evidence 
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for diagnostic purposes.  
1.3.2 Milk Somatic Cell Count 
Milk somatic cell counts refers to all cell types found in normal milk, which 
include lympocytes, macrophages and neutrophils from the blood and shedded epithelial 
cells from the lining of the gland. Macrophages are positioned in normal milk for 
immune recognition of invading pathogens and represent 66-88% of all cells in milk from 
non-infected quarters (Lee et al., 1980; Burvenich et al., 1994; Kelly et al., 2000). The 
proportion of neutrophils in normal milk is small (0-11%) but quickly become the 
predominant cell type (90%) in milk from infected quarters (Kehrli and Shuster, 1994; 
Paape et al., 2003).  
Milk somatic cell count (SCC) has been widely accepted and used to indicate the 
health status of bovine mammary glands, the quality of milk for human consumption and 
the hygiene conditions of dairy farms in most developed countries and in some 
developing countries (Ruegg and Tabone, 2000; Schukken et al., 2003; Heeschen, 2005). 
Many studies have shown that inflammation is the predominant factor affecting the 
concentrations of somatic cell counts in milk (Dohoo and Meek, 1982; Schepers et al., 
1997). Statistically, milk SCC over 300,000 cells/ml is a good indicator of abnormal milk 
and an infected or inflamed quarter. For this reason, herd bulk tank SCC (BTSCC) is 
monitored monthly to predict the udder health status in a herd in practice (Kehrli and 
Shuster, 1994; Jayarao and Wolfgang, 2003; Lee et al., 2003).  
However, quarter milk SCC can be below 200,000 cells/ml for mastitis caused by 
some minor pathogens (Harmon and Langlois, 1986; De Vliegher et al., 2003). Clearly, 
the nature of the pathogen has a significant effect on the dynamics of elevating SCC.  A 
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variety of other factors including heat stress, stage of lactation, lactation number, season 
and even diurnal variation can also contribute to the variations of SCC in normal milk to 
some extent (Paape et al., 1973; Sheldrake et al., 1983a; Harmon, 1994; Paape et al., 
2003). In addition, SCC can remain elevated for days or weeks after the resolution of an 
inflammation or the clearance of bacteria from the mammary gland (Schultz, 1977; 
Olsson et al., 1986; Emanuelson et al., 1987; Emanuelson et al., 1988; Pyorala, 1988).  
Somatic cell count can be determined accurately by automatic cell counters or 
estimated by performing a cow-side California Mastitis Test (CMT), or by measuring the 
adenosine triphosphate (ATP) (Olsson et al., 1986; Emanuelson et al., 1987; Emanuelson 
et al., 1988) or N-acetyl-ß-D-glucosaminidase (Kitchen et al., 1978) activity in milk. The 
CMT is based on the amount of cellular nuclear protein present in the milk sample. 
Because neutrophils are the predominant cell type present in milk, the CMT score 
correlates with the SCC level in the gland and is a widely used cow-side test for 
evaluation of SCC.  
1.3.3 Electrical Conductivity  
Electrical conductivity testing is based on the fact that mastitic milk has a higher 
electrical conductivity than normal milk due to the increase in sodium and chloride ions 
following the breakdown of the blood-milk barrier (Norberg et al., 2004). This method 
has promise of being  incorporated into the on-line automatic milk system to detect the 
real-time quality of milk. However, this analysis is less efficient in detecting subclinical 
mastitis compared with clinical mastitis (Nielen et al., 1995).  
1.4 Acute Phase Response and Acute Phase Proteins  
          The acute phase response (APR) is a systemic reaction of the host occurring within 
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the first 24-48 h in response to local or systemic disturbances caused  by infection, tissue 
injury, trauma or immunological disorders, which enables the host to rapidly generate a 
nonspecific response to various stimuli before the adaptive immune response slowly 
develops (Heinrich et al., 1990; Koj, 1996; Gabay and Kushner, 1999; Gruys et al., 2005). 
One hallmark of the APR is that liver hepatocytes can adjust their synthesis of plasma 
proteins, known as acute phase proteins, in response to induced  inflammatory cytokines 
including interleukin (IL)-1, IL-6 and TNFα (Heinrich et al., 1990; Fantuzzi and 
Dinarello, 1996; Moshage, 1997; Gruys et al., 2005).  
The circulating concentrations of some APPs change substantially in inflammation, 
displaying a relation with the severity of infection or the extent of tissue damage, making 
them good markers of inflammation and infection in both medical and veterinary clinical 
pathology (Eckersall and Conner, 1988; Pyorala, 1988; Murata et al., 2004; Ceron et al., 
2005; Gruys et al., 2006).  Haptoglobin is more sensitive to inflammation than 
hematological screening in studies with dogs and sheep respectively  (Solter et al., 1991; 
Skinner and Roberts, 1994). Serum amyloid A (SAA) and haptoglobin (Hap) have been 
shown to be good indicators to discriminate between acute and chronic inflammatory 
conditions in cattle (Horadagoda et al., 1999). Because there are species differences in the 
behavior of some APP (Gruys and Snel, 1994),  the following section will only focus on 
those diagnostically useful APP in cattle (Petersen et al., 2004).  
1.4.1 Serum Amyloid A  
   SAA is an apolipoprotein associated with high-density lipoprotein and is believed 
to modulate reverse cholesterol transport from dying cells at inflamed sites, thereby 
facilitating the uptake of free cholesterol by the hepatocytes (Coetzee et al., 1986; 
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Shephard et al., 1987; Liang and Sipe, 1995; Hayat and Raynes, 1997).  SAA is also a 
potent chemoattractant in recruiting T lymphocytes, neutrophils and monocytes into 
inflammatory sites (Badolato et al., 1994; Xu et al., 1995). SAA at clinically relevant 
concentrations is known to induce IL-8 expression and release from neutrophis and 
monocytes, which results in a typical uncontrolled inflammatory reaction usually 
associated with the development of degenerative diseases (Ribeiro et al., 2003). In 
addition, SAA can function as an immune opsonin for Gram-negative bacteria, enhance 
phagocytic activity against bacteria by neutrophils, promote neutrophil survival by 
suppressing the apoptosis and assisting in the detoxification of endotoxin (Xu et al., 1995; 
Badolato et al., 2000; Shah et al., 2006; El Kebir et al., 2007).  
Several isoforms of SAA have been reported with SAA-1 and SAA-2 produced in 
liver and SAA-3 in extra-hepatic tissues including macrophages, endothelial cells, 
intestinal epithelium and bovine mammary epithelial cells (DiBartola and Benson, 1989; 
Steel and Whitehead, 1994; McDonald et al., 2001; Vreugdenhil et al., 2003).   
In cattle, the potential for using increased blood concentration of SAA in the 
assessment of herd health has been widely studied in the context of viral diseases, 
bacteria infection and complex stress such as weaning, mixing and transportation. In 
general, an increase in SAA blood concentration was observed although the magnitude 
and duration of  elevated concentrations varies (Heegaard et al., 2000; Ganheim et al., 
2003; Petersen et al., 2004; Lomborg et al., 2008).   
1.4.2 Lipopolysaccharide Binding Protein  
         Lipopolysaccharide (LPS) is the main cell component of Gram-negative bacteria 
with no enzymatic or intrinsic activity. The “toxicity” of LPS is conferred entirely by the 
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injurious ways that the host senses the presence of LPS (Munford, 2005). Diverse as the 
effects of LPS, the recognition of LPS by the host uses the same core pathway which 
involves LBP-mediated sequential interaction with CD14, MD-2 and Toll-like-receptor 
4(TLR4) followed by activation of the inflammatory host response (Wright et al., 1990; 
Shimazu et al., 1999; Visintin et al., 2003). 
As the first biologically relevant receptor of LPS, LBP can catalyze the transfer of 
LPS to CD14 (Tobias et al., 1995), either membrane-bound (Wright et al., 1990) or 
soluble (Pugin et al., 1993), thus leading to activation of a wide variety of cell types 
including mCD14 –positive myeloid cells and mCD14-negative cells such as endothelial 
and epithelial cells. Whereas LBP knockout mice are less susceptible to LPS, LBP 
deficient mice are more likely to succumb to infections by whole live bacteria including 
Salmonella and Klebsiella pneumoniae characterized by a delayed PMN influx and 
uncontrolled bacteria growth (Gallay et al., 1994; Jack et al., 1997; Le Roy et al., 2001; 
Fierer et al., 2002).  
In addition to this beneficial pro-inflammatory role, LBP can exert anti-
inflammation effects by not yet understood mechanisms, depending on LBP 
concentration and the cellular environment. Administration of a high dose of recombinant 
LBP intraperitoneally protects mice from Escherichia coli peritonitis and from 
intraperitoneal LPS injection, indicating that high concentrations of LBP in extravascular 
fluids may help control responses to LPS (Lamping et al., 1998). Three inhibitory 
mechanisms have been proposed to explain this finding. First, LBP can redirect LPS 
away from monocytes and macrophages by transferring it to plasma lipoproteis (Wurfel 
et al., 1994; Vesy et al., 2000; Kitchens et al., 2003). Secondly, higher concentrations of 
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LBP can promote the removal of the mCD14-bound LPS and interfere with the 
subsequent interaction with MD-2 and TLR4 (Thompson et al., 2003). The third 
inhibitory mechanism involves the formation of larger extracelluar LBS-LBP complexes 
that have a reduced ability to stimulate cells (Gegner et al., 1995; Gioannini et al., 2003; 
Hamann et al., 2005).  
Besides hepatocytes, lungs and intestinal epithelial cells represent minor additional 
sources of LBP (Su et al., 1994; Dentener et al., 2000; Vreugdenhil et al., 2003). Local 
production of LBP is also closely associated with a protective role through enhancing the 
inflammatory response to low doses of LPS while inhibiting the inflammatory response 
to high doses of LPS (Fierer et al., 2002; Yang et al., 2002; Knapp et al., 2006).  
Finally, LBP may participate in the recognition of Gram-positive bacterium. 
Whereas LBP has been shown to play an indispensable role in the recognition of such 
cell wall components of Gram-positive bacterium such as peptidoglycan (PGN) or 
lipoteichoic acid (LTA) in vitro (Dziarski et al., 1998; Fan et al., 1999; Morath et al., 
2001; Schroder et al., 2003),  evidence for such a role in infections caused by Gram-
positive bacteria in vivo is still conflicting (Dziarski et al., 1998; Fan et al., 1999; Morath 
et al., 2001; Schroder et al., 2003; Vreugdenhil et al., 2003; Weber et al., 2003; Branger 
et al., 2004; Brass et al., 2004; Knapp et al., 2008). 
Bovine LBP is a 58 kDa glycoprotein  and  functions similar to human LBP to 
present LPS to host cells with comparable results (Tobias et al., 1986; Horadagoda et al., 
1995; Tobias et al., 1995). Also as in humans, LBP participates in acute phase responses 
in cattle and has been proven to be a diagnostic marker in cattle infection (Schroedl et al., 
2001; Bannerman et al., 2003; Nikunen et al., 2007). 
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1.4.3 Haptoglobin 
Haptoglobin (Hap) is a plasma protein with an ability to bind free hemoglobin 
released from erythrocytes and thereby prevents free Hb in the circulation from passing 
through the glomerular filter and resulting in renal damage during intravascular 
hemolysis. During the process of binding hemoglobin, Hap also sequesters the iron 
within hemoglobin, making it unavailable to bacteria and thus is considered as a 
bacteriostatic agent and an APP (Barclay, 1985; Langlois and Delanghe, 1996). The 
Haptoglobin-hemoglobin complex is later cleared in the liver by the reticuloendothelial 
system through CD163 receptor-mediated endocytosis (Kristiansen et al., 2001; 
Graversen et al., 2002). 
In addition to its classical role of binding hemoglobin, Hap has a broad range of 
anti-inflammatory activities. Hap antagonizes endotoxin effects by suppressing monocyte 
production of TNFα (Arredouani et al., 2005). It may also play a role in modulating 
immune cell response by binding receptors such as the β2-integrin CD11b/CD18 on 
monocytes, granulocytes, natural killer cells, CD22 lectin on B cells and CD163 
scavenger receptor on macrophages (El Ghmati et al., 1996; Wassell, 2000). Although no 
Hap receptor has been described for T cells, studies performed in vivo and in tissue 
culture indicated purified Hap had a moderate inhibitory effect on T cells (Arredouani et 
al., 2001; Arredouani et al., 2003; Arredouani et al., 2005). Results from Hap knockout 
mice show that Hap expression per se contributes to the normal development and 
differentiation of the immune system while inflammation-induced Hp fine-tunes an 
optimal immune response (Huntoon et al., 2008). 
In cattle, increased Hap concentrations in blood are observed under a variety of  
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experimental infections with P.multocida ,P.haemolytica, bovine respiratory syncytial 
virus or natural infections with foot-and-mouth disease virus and clinical respiratory tract 
disease(Hofner et al., 1994; Wittum et al., 1996; Katoh and Nakagawa, 1999; Heegaard et 
al., 2000; Dowling et al., 2002). The concentration of Hap is reported to be correlated 
with clinical signs in cattle inoculated with bBovine herps virus 1 and P. haemolytica 
separately (Godson et al., 1996). Therefore, its role as a marker of various inflammatory 
diseases has long been recognized (Alsemgeest et al., 1995; Petersen et al., 2004). 
1.5 Acute Phase Proteins in the Diagnosis of Mastitis 
As in other inflammatory diseases, APP’s are also induced in bovine mastitis. 
Hepatocyte derived APP’s can also be found in milk from inflamed quarters as a result of 
breakdown of the milk-blood barrier. Recent research also shows that Hap and SAA can 
be induced in bovine mammary glands in response to IMI (Eckersall et al., 2001; Larson 
et al., 2005; Eckersall et al., 2006; Weber et al., 2006; Thielen et al., 2007).  
Concentrations of SAA and Hap have been shown to increase in both blood and 
milk of cows with clinical and subclinical mastitis, either experimentally induced 
(Horadagoda et al., 1999; Gronlund et al., 2003; Hiss et al., 2004; Eckersall et al., 2006) 
or naturally occurring (Eckersall et al., 2001; Nielsen et al., 2004; Gronlund et al., 2005; 
Eckersall et al., 2006; O'Mahony et al., 2006; Akerstedt et al., 2007). However, there is 
no agreement regarding the relative diagnostic value of Hap and SAA as biomarkers for 
the identification of infection status of the mammary gland and the severity of 
inflammation.  
LBP is another important APP in the bovine (Khemlani et al., 1994; Horadagoda 
et al., 1995) and its concentration displays a very early increase and a temporal change 
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coincident with that of the increases in milk SCC in experimentally induced clinical 
mastitis with LPS and several species of bacteria including S.aureus, E.coli, S. 
marcescens and S. uberis (Bannerman et al., 2003; Bannerman et al., 2004a; Bannerman 
et al., 2004b; Bannerman et al., 2004c; Bannerman et al., 2005).However, whether this 
correlation found in experimentally induced clinical mastitis also exists in cows with 
























Chapter 2: Materials and Methods 
2.1 Animals 
 Blood and milk samples were collected from lactating Holstein cows in the 
USDA-ARS Beltsville Area dairy herd.  The use and care of all animals in this study was 
approved by the Beltsville Area Animal Care and Use Committee.  Two experiments 
were conducted that involved sample collection from cows in the herd.  In the first 
experiment, blood and milk samples were collected from 101 clinically healthy lactating 
cows.  In the second experiment, all cows in the herd were monitored over a four month 
period for visible signs of clinical mastitis, including abnormal milk secretions and/or 
quarters that were red, swollen, or hard.  During this period, a total of 17 cows were 
diagnosed with clinical mastitis and sampled. 
2.2 Sample Collection 
 Milk samples were aseptically collected by spraying each teat with an iodine-
based disinfectant, forestripping, wiping off the disinfectant with a paper towel, and 
scrubbing each teat with sterilized gauze pads saturated with 70% ethanol.  Following 
cleaning and disinfection of the teats, milk samples were collected into sterile tubes.  
Blood samples were drawn from the coccygeal vein of each animal using a 20 gauge 
Vacutainer® needle and collected into glass tubes containing K2 EDTA (Becton-
Dickinson Corp., Franklin, Lakes, NJ). 
2.3 Whey and Plasma Preparation 
 For the preparation of whey, milk samples were centrifuged at 44,000 × g at 4 °C 
for 30 min and the fat layer was removed with a spatula.  The skimmed milk was 
centrifuged again for 30 min as above, and the translucent supernatant collected, 
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aliquotted, and stored at -70 °C.  For the preparation of plasma, blood samples were 
centrifuged at 1,500 × g for 15 min, and the clear supernatant collected, aliquotted, and 
stored at -70 °C. 
2.4 Detection of Milk SCC and Bacterial Examination  
 For the quantification of somatic cells, milk samples were heated to 60 °C and 
subsequently maintained at 40 °C until the cells were counted on an automated milk 
somatic cell counter (Bentley Instruments, Inc., Chaska, MN).  For bacteriological 
analysis of milk samples collected during both experiments, all quarters were sampled 
twice over two consecutive days.  Twenty and 100 µL of each sample were plated on 
blood and MacConkey agar plates (Becton-Dickinson Corp.), respectively.   The plates 
were incubated for 24 h at 37 ºC and visually examined.  If bacterial colonies were not 
evident, plates were incubated for an additional 24 h at 37 ºC and re-examined.  Bacterial 
colonies were identified using standard microbiological procedures, including Gram 
staining and catalase and coagulase testing, in accordance with previously published 
guidelines (NationalMastitisCouncil, 1999).  When inconsistent bacteriological results 
were obtained from two samples obtained from a given quarter, a third sample was 
collected and bacteriological analysis performed.   
2.5 Enzyme-linked Immunosorbent Assays for BSA, LBP, SAA and Hap 
 BSA concentrations were assayed using a commercially available ELISA (Bethyl 
Laboratories, Inc., Montgomery, TX).  The assay was performed as previously described 
(Bannerman et al., 2003) with the exception that wells were coated with 10 µg/ml of 
sheep anti-bovine BSA antibodies for 1 h at room temperature instead of overnight at 4 
°C.  Whey samples were diluted between 1:2,500 and 1:60,000 so that they were within 
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the linear range of the assay.  The limit of detection of this assay was 0.98 µg/ml. The 
inter-assay and intra-assay coefficient of variance (CV) for BSA analysis was <5% and 
<10%. LBP concentrations were determined with a commercial ELISA kit (Cell Sciences, 
Inc., Canton, MA) as previously described (Bannerman et al., 2003).  Whey samples were 
diluted between 1:10 and 1:9,000 and plasma samples diluted between 1:500 and 1:4,500 
so that they were within the linear range of the assay. The limit of detection of this assay 
for whey and plasma samples was 0.008 µg/ml and 0.4 µg/ml respectively. The inter-
assay and intra-assay CV for LBP analysis was <13% and <9%  (Suojala et al., 2008). 
Hap concentrations were determined with a commercial ELISA kit (Alpco 
Diagnostics, Salem, NH) according to the manufacturer’s instructions.  Whey samples 
were diluted between 1:10 and 1:500 and plasma samples diluted between 1:100 and 
1:10,000 so that they were within the linear range of the assay.  Plates were analyzed at a 
wavelength of 450 nm and a correction wavelength of 565 nm using a microplate reader 
(Bio-Tec Instruments, Inc., Winooski, VT). The limit of detection of this assay for whey 
and plasma was 0.02 µg/ml and 0.2 µg/ml respectively. The concentrations of Hap in the 
samples were calculated by extrapolation from a standard curve of known amounts of 
bovine Hap. The inter-assay and intra-assay CV for Hap analysis were both <10%. 
             SAA concentrations in plasma and whey were determined with two commercial 
ELISA kits respectively (Milk Amyloid A Assay and Serum Amyloid A Assay, Tridelta 
Development Ltd, Wicklow, Ireland). Whey samples were diluted between 1:10 and 
1:500 and plasma samples diluted between 1:50 and 1:4,000 so that they were within the 
linear range of the assay. The limit of detection of the assay for whey and plasma samples 
was 0.047 µg/ml and 0.23 µg/ml respectively. The inter-assay and intra-assay CV for 
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milk Amyloid A analysis were <15% and 10% while those for SAA were <12% and 9% 
respectively.  
2.6 Statistical Methods 
 A generalized linear model with lognormal distribution and identity link was fit to 
each dependent variable using SAS® Proc GLIMMIX (SAS Institute, 2006).  For the 
analysis of the effects and interaction of bacteriological status (i.e., non-infected or 
infected) and SCC (i.e., <250,000 or >250,000 cells/ml) on a given dependent variable in 
samples derived from healthy and subclinically infected cows, a two-way ANOVA model 
was specified.  For the analysis of the effects of the type of infection (i.e., clinically 
infected, subclinically infected, or non-infected) on a given dependent variable, a one-
way ANOVA model was specified.  Significant differences, α=0.05, among treatment 
means were identified using the Extended Shaffer-Royen (ESR) multiple comparisons 
method (Westfall and Tobias, 2007) by specifying ADJUST=SIMULATE and 
STEPDOWN options in the LSMEANS statement (SAS Institute, 2006).  A P-value of 









Chapter 3:  Results 
3.1 Milk Samples from Clinically Healthy Cows 
3.1.1 Bacteriological Results and SCC  
 In order to evaluate the milk concentrations of APP in subclinically infected 
mammary glands, milk samples were collected from 393 quarters of 101 clinically 
healthy cows.  Of the samples plated, 55 were positive for bacterial growth, and the 
quarters from which these samples were derived were classified as subclinically infected.  
Diagnostic microbiological testing identified coagulase-negative staphylococci (CNS) as 
the most prevalent pathogen among the subclinically infected quarters (Table 1).  The 
second most prevalent pathogen isolated was Staphylococcus aureus.  Together, these two 
pathogens accounted for 84% of the subclinical intramammary infections.  Other 
pathogens isolated included Streptococci spp., Gram-negative bacilli, Bacillus cereus, 
Corynebacterium bovis, and yeast. 
 SCC was detected in milk from 316 (93%) non-infected quarters and all infected 
quarters and its concentrations ranged from 0 to 3361×103 cells/ml in non-infected 
quarters and from 2 to 13020×103 cells/ml (Table 2). The milk SCC of the 55 subclinically 
infected quarters (851 ±319 x 103 cells/ml) were approximately 9-fold higher (P < 0.0001) 
than those of the non-infected quarters (86 ± 13 × 103 cells/ml) (Fig. 1A).  For subsequent 
analysis of the effect of SCC on milk APP concentrations, samples were also analyzed on 
the basis of defined grouping by low (<250,000 cells/ml) or high (>250,000 cells/ml) 
SCC regardless of infection status (Fig. 1B).  Correspondingly, there was a significant 
difference in SCC between the two groups (P < 0.0001).  Samples were also analyzed on 
the basis of both infection status and SCC grouping (Fig. 1C).  Of the 347 quarters with 
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milk SCC <250,000 cells/ml, 36 (~10%) were positive for bacterial growth.  The SCC of 
these quarters (94 ± 11 × 103 cells/ml) differed (P < 0.0001) from those of non-infected 
quarters (40 ± 3 × 103 cells/ml) in the low SCC group.  Of the 46 quarters with milk SCC 
>250,000 cells/ml, 19 (~41%) were positive for bacterial growth.  The SCC of these 
quarters (2,284 ± 841× 103 cells/ml) approached, but did not reach, a level that was 
significantly different (P = 0.0865) from those of non-infected quarters (616 ± 114 × 103 


















Table 1.  Bacteriological analysis of milk samples from cows that were either clinically 
healthy and had at least one subclinically infected quarter or had at least one quarter 
diagnosed with clinical mastitis.                   
 
  Clinically Healthy Cows  Clinical Mastitis Cows 
Bacteria
a
  Subclinically Infected
b





      
CNS  38
e
  11 3 
S. aureus  8  3 2 
Streptococci  3  1 1 
Gram-negative  2  2 2 
B. cereus  2  1 1 
C. bovis  1  2 1 
Yeast  1  1 1 
No growth  NA  NA 7 
 
Total  55  21 18 
 
a
 CNS:  coagulase-negative Staphylococci; S. aureus:  Staphylococcus aureus; B. cereus: Bacillus 
cereus; C. bovis: Corynebacterium bovis; NA:  not applicable 
b 
Bacteriological results of milk samples obtained from subclinically infected quarters of clinically 
healthy cows.   
c 
Bacteriological results of milk samples obtained from subclinically infected quarters of cows with 
one or more quarters diagnosed with clinical mastitis. 
d 
Bacteriological results of milk samples obtained from quarters diagnosed with clinical mastitis. 
e 
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Fig. 1.  Somatic cell counts (SCC) of milk samples obtained from clinically healthy cows.  Milk 
samples were collected from 393 quarters of 101 clinically healthy cows and analyzed for SCC.  Data 
are presented on the basis of infection status (non-infected versus subclinically infected) (A), SCC 
grouping (<250,000 versus >250,000 cells/ml) (B), or both (C), and reported as mean (± S.E.) counts 
in thousands per milliliter. Different alphabets denote statistically significant (P < 0.05) differences 
between groups. 
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3.1.2 BSA Concentrations  
 As an indicator of increased vascular permeability and breakdown of the milk-
blood barrier, milk BSA concentrations were analyzed as a marker of local inflammation 
in milk samples collected from the healthy and subclinically infected quarters of 
clinically healthy cows.  BSA concentrations were above the limit of detection in all milk 
samples with concentrations ranging from 16.17 to 3258.65 µg/ml for non-infected 
quarters and from 12.32 to 944.66 µg/ml for subclinically infected quarters (Table 2). On 
the basis of infection status alone, there were no significant differences in the BSA 
concentrations of milk samples obtained from subclinically infected versus non-infected 
quarters (Fig. 2A).  On the basis of SCC grouping alone, milk BSA concentrations were 
higher (P = 0.0265) in milk samples with SCC >250,000 cells/ml (388 ± 37 µg/ml) than 
in those with SCC <250,000 cells/ml (300 ± 14 µg/ml) (Fig. 2B).  Analysis of samples on 
the basis of both SCC grouping and infection status identified comparable milk BSA 
concentrations among samples from subclinically infected and non-infected quarters in 
the low SCC group, as well as between those from subclinically infected and non-









Table 2. Range of concentrations of somatic cell counts (SCC), bovine serum 
albumin(BSA), LPS binding protein(LBP), haptoglobin(Hap) and amyloid A(AA) in milk 
samples from clinically healthy  cows. 
 





SCC(103 cells/ml) 316/338 0-3361 55/55 2-13020 
BSA(µg/ml) 338/338 16.17-3258.65 55/55 12.32-944.66 
LBP(µg/ml) 337/338 <0.008-38.94 55/55 0.32-29.65 
Hap(µg/ml) 278/338 <0.02-47.09 52/55 <0.02-85.85 
AA(µg/ml) 15/338 <0.047-2.39 6/55 <0.047-1.08 
 
aNumber of milk samples with a concentration greater than the limit of detection of the assay 
used/ total number of milk samples. 
b Data for milk samples from non-infected quarters of clinically healthy cows.  
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Fig. 2.  Bovine serum albumin (BSA) concentrations in milk samples obtained from clinically healthy 
cows.  The BSA concentrations of milk samples collected from 393 quarters of 101 clinically healthy 
cows were determined by ELISA.  Data are presented on the basis of infection status (non-infected 
versus subclinically infected) (A), somatic cell count (SCC) grouping (<250,000 versus >250,000 
cells/ml) (B), or both (C), and reported as mean (± S.E.) milk BSA concentrations in micrograms per 
milliliter. 
 
Different alphabets denote statistically significant (P < 0.05) differences between groups. 
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3.1.3 LBP Concentrations  
 The concentrations of LBP were determined by ELISA in milk samples collected 
from the healthy and subclinically infected quarters of clinically healthy cows. LBP was 
detected in milk from 337 (99%) non-infected quarters and all infected quarters and their 
concentrations ranged from below 0.008 to 38.94 µg/ml for non-infected quarters and 
from 0.32 to 29.65 µg/ml for subclinically infected quarters (Table 2 ). On the basis of 
infection status alone, milk LBP concentrations were comparable between non-infected 
and subclinically infected quarters (Fig. 3A).  On the basis of SCC grouping irrespective 
of infection status, milk LBP concentrations were higher (P = 0.0032) in milk samples 
with SCC >250,000 cells/ml (12.78 ± 1.39 µg/ml) than in those with SCC <250,000 
cells/ml (6.20 ± 0.33 µg/ml) (Fig. 3B).  Analysis of samples on the basis of both SCC 
grouping and infection status revealed a significant difference (P = 0.0357) in milk LBP 
concentrations between non-infected and subclinically infected quarters where SCC was 
<250,000 cells/ml (Fig. 3C).  In samples with high SCC (>250,000 cells/ml), there were 
no significant differences (P = 0.1699) in milk LBP concentrations between non-infected 



















































































Fig. 3.  Lipopolysaccharide-binding protein (LBP) concentrations in milk samples obtained from 
clinically healthy cows.  The LBP concentrations of milk samples collected from 393 quarters of 101 
clinically healthy cows were determined by ELISA.  Data are presented on the basis of infection status 
(non-infected versus subclinically infected) (A), somatic cell count (SCC) grouping (<250,000 versus 
>250,000 cells/ml) (B), or both (C), and reported as mean (± S.E.) milk LBP concentrations in 
micrograms per milliliter.  Different alphabets denote statistically significant (P < 0.05) differences 
between groups. 
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3.1.4 Milk haptoglobin concentrations 
 The concentrations of Hap were determined by ELISA in milk samples collected 
from the healthy and subclinically infected quarters of clinically healthy cows.  Hap was 
detected in milk from 278 (82%) non-infected and 52 (94%) subclinically-infected 
quarters. Their concentrations ranged from below 0.008 µg/ml to 47.09 µg/ml for non-
infected quarters and from below 0.008 µg/ml to 85.85 µg/ml for subclinically infected 
quarters (Table 2). On the basis of infection status alone, milk Hap concentrations were 
higher (P = 0.0013) in those quarters that were subclinically infected (4.12 + 1.65 µg/ml) 
than in those that were uninfected (0.82 ± 0.21 µg/ml ) (Fig. 4A).  On the basis of SCC 
grouping irrespective of infection status, milk Hap concentrations were higher (P < 
0.0001) in milk samples with SCC >250,000 cells/ml (7.18 ± 2.10 µg/ml) than in those 
with SCC <250,000 cells/ml (0.50 ± 0.15 µg/ml) (Fig. 4B).  Analysis of samples on the 
basis of both SCC grouping and infection status revealed a significant difference (P = 
0.0001) in milk Hap concentrations between non-infected and subclinically infected 
quarters where SCC was <250,000 cells/ml (Fig. 4C).  In samples with high SCC 
(>250,000 cells/ml), there were no significant differences (P = 0.1927) in milk Hap 







































































































Fig. 4.  Haptoglobin concentrations in milk samples obtained from clinically healthy cows.  The 
haptoglobin concentrations of milk samples collected from 393 quarters of 101 clinically healthy cows 
were determined by ELISA.  Data are presented on the basis of infection status (non-infected versus 
subclinically infected) (A), somatic cell count (SCC) grouping (<250,000 versus >250,000 cells/ml) 
(B), or both (C), and reported as mean (± S.E.) milk haptoglobin concentrations in micrograms per 
milliliter.   Different alphabets denote statistically significant (P < 0.05) differences between groups. 
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3.1.5. Milk Amyloid A Concentrations 
 The concentrations of milk Amyloid A were determined by ELISA in milk 
samples collected from the healthy and subclinically infected quarters of clinically 
healthy cows.  Milk Amyloid A was detected from 15 (4.4%) non-infected and 6 (10.9%) 
subclinically infected quarters and their concentrations ranged from below 0.047 to 2.39 
µg/ml for non-infected quarters and from below 0.047 to 1.08 µg/ml for subclinically 
infected quarters (Table 2). On the basis of infection status alone, there were no 
significant differences (P =0.8561) in the SAA concentrations of milk samples obtained 
from subclinically infected versus non-infected quarters (Fig. 5A).  On the basis of SCC 
grouping alone, milk SAA concentrations were higher (P = 0.0094) in milk samples with 
SCC >250,000 cells/ml (0.12 ± 0.057 µg/ml) than in those with SCC <250,000 cells/ml 
(0.0085 ± 0.0027µg/ml) (Fig. 5B).  Analysis of samples on the basis of both SCC 
grouping and infection status identified comparable milk SAA concentrations among 
samples from subclinically infected and non-infected quarters in the low SCC group, as 
well as between those from subclinically infected and non-infected quarters in the high 
























































































Fig. 5.  Amyloid A concentrations in milk samples obtained from clinically healthy cows.  The 
Amyloid A concentrations of milk samples collected from 393 quarters of 101 clinically healthy cows 
were determined by ELISA.  Data are presented on the basis of infection status (non-infected versus 
subclinically infected) (A), somatic cell count (SCC) grouping (<250,000 versus >250,000 cells/ml) 
(B), or both (C), and reported as mean (±S.E.) milk Amyloid A concentrations in micrograms per 
milliliter.  Different alphabets denote statistically significant (P < 0.05) differences between groups. 
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3.2 Milk Samples from Cows with Clinical Mastitis 
3.2.1 Bacteriological Results, SCC, and BSA Concentrations 
 In order to evaluate the milk concentrations of APP in mammary glands showing 
clinical signs of disease, milk samples were collected from 17 cows with naturally-
occurring clinical mastitis.  Samples were obtained at the first sign of clinical mastitis 
during the morning or evening milking and collected from all quarters.  With the 
exception of one cow that had clinical symptoms in two quarters, all other cows sampled 
had only one quarter with clinical mastitis.  Of the milk samples isolated from the 
remaining quarters showing no clinical signs of disease, 21 were positive for bacterial 
growth and the corresponding quarters classified as subclinically infected.  Among the 
quarters of these cows that showed either clinical mastitis or were subclinically infected, 
CNS, S. aureus, and Gram-negative bacilli were the most prevalent bacteria recovered 
(Table 1).  Twenty-two quarters were free of infection and had milk SCC <250,000 
cells/ml.  These quarters were classified as healthy based on the absence of infection and 
inflammation.  
 Among the cows with clinical mastitis, the milk SCC was detected in all milk 
samples and its concentration ranged from 8 × 103 to 179 × 103 cells/ml, 1.5 × 103  to 
2525 × 103 cells/ml and 26 × 103  to 157750 × 103 cells/ml for healthy quarters, 
subclinically infected quarters and clinically infected quarters, respectively (Table 3). The 
milk SCC of the quarters with clinical signs (18,553 ± 9,596 × 103 cells/ml) were 
approximately 42-fold higher (P = 0.0002) than those of subclinically infected quarters 
(434 ± 175 × 103 cells/ml) (Fig. 6A).  The SCC of the healthy quarters of these cows (44 
± 10 × 103 cells/ml) were lower than those of the quarters showing clinical signs (P < 
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0.0001) or that were subclinically infected (P = 0.0189).  BSA was detected in all milk 
samples (Table 2) and its concentrations ranged from 36.67 to 3905.6 µg/ml, 100.20 to 
710.97 µg/ml and 125.85 to 18508 µg/ml for healthy quarters, subclinically infected 
quarters and clinically infected quarters respectively (Table 3). The milk BSA of these 
cows were higher in the quarters with clinical mastitis (2,143 ± 1,054 µg/ml) than in 
those quarters that had a subclinical infection (329 ± 37 µg/ml; P = 0.0204) or were 
healthy (374 ± 170 µg/ml; P = 0.0021) (Fig. 6B).  There was no difference (P = 0.2371) 
between the milk BSA concentrations of the non-infected and subclinically infected 
















Table 3. Range of concentrations of somatic cell counts (SCC), bovine serum albumin 
(BSA), LPS binding protein (LBP), haptoglobin (Hap) and amyloid A (AA) in milk 
samples from cows with clinical mastitis. 
Non-Infected  
SCC<250,000b 
Subclinically Infected  
Quartersc 









SCC(103 cells/ml) 22/22 8-179 21/21 1.5-2525 18/18 26-157750 
BSA(µg/ml) 22/22 36.7-3905.6 21/21 100.2 -710.9 18/18 125.9-18508 
LBP(µg/ml) 22/22 0.39-42.3 21/21 1.06-41.73 17/18 <0.4-47.8 
Hap(µg/ml) 22/22 0.026-48.8 20/21 <0.02-61.17 18/18 1.77-841.1 
AA(µg/ml) 7/22 <0.047-6.9 15/21 <0.047-7.71 13/18 <0.047-129.4 
 
a Number of milk samples with a concentration greater than the lower detection limit of the assay 
used/ total number of milk samples. 
b Data for milk samples from quarters that were free of infection and with SCC below 250,000 
cells/ml of cows with clinical mastitis.  
c Data for milk samples from subclinically infected quarters of cows with clinical mastitis.  
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Fig. 6.  Measurement of indices of inflammation in milk samples obtained from cows with clinical 
mastitis.  Milk samples were collected from all quarters of 17 cows diagnosed with clinical mastitis in 
one or more quarters.  Milk samples from the quarters were divided into three groups on the basis of:  
(1) absence of bacterial growth after plating, somatic cell counts (SCC) <250,000 cells/ml, and 
absence of any clinical signs of disease in the quarter from which the sample was collected; (2) 
presence of bacterial growth and absence of any clinical signs of disease in the quarter from which the 
sample was collected (subclinically infected); and (3) presence of clinical signs of disease in the 
quarter from which the sample was collected (clinical mastitis).  The milk SCC of the samples were 
determined and reported as mean (± S.E.) counts in thousands per ml (A).  The bovine serum albumin 
(BSA) (B), lipopolysaccharide-binding protein (LBP) (C), haptoglobin (D) and amyloid A (E) 
concentrations in the samples were determined by ELISA and reported as mean (±S.E.) concentrations 
in micrograms per milliliter. 
 















3.2.2 LBP, Haptoglobin and Amyloid A  Concentrations 
 In cows with clinical mastitis, LBP was detected in all milk samples except one 
from clinically infected quarter and its concentrations ranged from 0.39 to 42.30 µg/ml, 
1.06 to 41.73 µg/ml and <0.4 to 47.88 µg/ml for healthy quarters, subclinically infected 
quarters and clinically infected quarters respectively (Table 3). Those quarters that 
showed clinical signs of disease (19.64 ± 4.50 µg/ml) or were subclinically infected 
(17.29 ± 3.64 µg/ml) had higher (P = 0.0464 and 0.0489, respectively) milk 
concentrations of LBP than corresponding healthy quarters (8.37 ± 2.61 µg/ml) (Fig. 6C).  
There was no difference (P = 0.5979), however, in the milk LBP concentrations of the 
quarters of these cows that showed clinical signs versus those quarters that were 
subclinically infected. Haptoglobin was detected in all milk samples except one from 
subclinically infected quarter and its concentration ranged from 0.026 to 48.83 µg/ml, 
<0.02 to 61.17 µg/ml and 1.77 to 841.01 µg/ml for healthy quarters, subclinically 
infected quarters and clinically infected quarters respectively (Table 3).  Similar to LBP, 
milk haptoglobin concentrations in quarters with clinical signs (78.72 ± 47.28 µg/ml) or 
subclinical infections (12.27 ± 3.80 µg/ml) were higher (P < 0.0001 and P = 0.0003, 
respectively) than those in the healthy quarters (3.45 ± 2.20 µg/ml) of the same cows (Fig. 
6 D).  The haptoglobin concentrations of milk samples obtained from the quarters of 
these cows that were subclinically infected versus those that demonstrated clinical signs 
differed by a level that approached (P = 0.0666) statistical significance. Milk amyloid A 
was detected in 7 (32%) healthy quarters, 15 (71.42%) subclinically infected quarters and 
13(72.22%) infected quarters and its concentration ranged from <0.047 to 6.92 µg/ml, 
<0.047 to 7.71 µg/ml and <0.047 to 129.42 µg/ml for healthy quarters, subclinically 
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infected quarters and clinically infected quarters respectively (Table 3).However, there 
was no difference in the milk SAA concentrations between quarters that showed clinical 
signs and those subclinically infected  (P = 0.0626)  or healthy quarters(P = 0.1229) as 
well as between  subclinically infected quarters and healthy quarters(P = 0.2822)(Fig. 6E).  
3.3 Blood Samples from Clinically Healthy Cows and Cows with Clinical 
Mastitis 
 In order to evaluate the effect of naturally-occurring clinical mastitis on APP 
blood concentrations, blood samples were obtained from the 17 cows diagnosed with 
clinical mastitis.  For comparison, blood samples obtained from the 101 clinically healthy 
cows were segregated into two groups, those from cows with all 4 quarters that were free 
of infection and had milk SCC <250,000 cells/ml (n = 47) and those from cows with at 
least one quarter that was subclinically infected (n = 39). 
 LBP was detected in all blood samples and its concentration ranged from 0.16 to 
101.33 µg/ml, 1.79 to 180.48 µg/ml and 11.72 to 259.59 µg/ml for cows with all healthy 
quarters, subclinical intramammary infections, or clinical mastitis respectively(Table 4).  
Blood concentrations of LBP were higher in cows with clinical mastitis  (113.12 ± 17.48 
µg/ml) than in those with subclinical intramammary infections  (35.10 ± 6.31 µg/ml; P < 
0.0001) or all healthy quarters (23.16 ± 3.19 µg/ml; P < 0.0001) (Fig. 7A).  There was no 
difference (P = 0.1390) between the blood LBP concentrations of non-infected cows and 
those with subclinical intramammary infections. Hap was detected in blood from 33(70%) 
cows with all healthy quarters, 29(74%) cows with subclinically infected quarters and all 
17 cows with clinical mastitis  and its concentration ranged from <0.2 to 28.66 µg/ml, 
<0.2 to 422.97 µg/ml and 1.18 to 4843.52 µg/ml for these three groups 
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correspondingly(Table 4). Similar to LBP, blood haptoglobin concentrations were 
significantly higher in cows with clinical mastitis than in cows with all healthy quarters 
or at least one quarter with a subclinical infection (Fig. 7B).  In contrast to LBP, the 
concentrations of haptoglobin were higher (P = 0.0499) in the blood of cows with a 
subclinical intramammary infection versus those with all healthy quarters.  The blood 
concentrations of haptoglobin in cows with all healthy quarters, subclinical 
intramammary infections, or clinical mastitis, were 1.45 ± 0.7 µg/ml, 23.31 ± 13.16 
µg/ml, and 1,732.61 ± 314.27 µg/ml, respectively.   
           In contrast to its relatively low detection rate in milk samples, SAA was detected 
in all blood samples and its concentration ranged from 0.81 to 154.23 µg/ml, 1.57 to 
469.32 µg/ml and 20.0 to 323.61 µg/ml for cows with all healthy quarters, subclinical 
intramammary infections, or clinical mastitis respectively. (Table 4). Similar to 
haptoglobin and LBP, blood SAA concentrations were higher(163.15 ± 25.47 µg/ml) in 
cows with clinical mastitis than in cows with all healthy quarters(31.95 ± 4.71 µg/ml; P 
<0.0001) or at least one quarter with a subclinical infection(85.19 ± 18.40 µg/ml; P = 
0.0012) (Fig. 7 C). Similar to haptoglobin and in contrast to LBP, the concentrations of 
SAA were higher (P = 0.0086) in the blood of cows with a subclinical intramammary 
infection versus those with all healthy quarters. 
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Table 4. Range of concentrations of LPS binding protein (LBP), haptoglobin (Hap) and 
serum amyloid A (SAA) in plasma samples from clinically healthy cows and cows with 
clinical mastitis. 
Non-Infected, SCC<250,000b Subclinically Infected c clinically Infected d  
Samples 





LBP(µg/ml) 47/47 0.16-101.33 39/39 1.79-180.48 17/17 11.72-259.59 
Hap(µg/ml) 33/47 <0.2-28.66 29/39 <0.2-422.97 17/17 1.18-4843.52 
SAA(µg/ml) 47/47 0.81-154.23 39/39 1.57-469.32 17/17 20.0-323.61 
 
a Number of milk samples with a concentration greater than the lower detection limit of the assay 
used/ total number of milk samples. 
b Data for blood samples from cows with all quarters that were free of infection and had SCC 
below 250,000 cells/ml.  
c Data for blood samples from cows with one or more quarters that were subclinically infected. 



























































































































Fig. 7.  Measurement of acute phase protein concentrations in blood samples obtained from cows with 
subclinical intramammary infections or clinical mastitis.  Blood samples were obtained from:  (1) 
clinically healthy cows that were free of infection and had milk somatic cell counts (SCC) <250,000 
cells/ml in all quarters; (2) clinically healthy cows with at least one quarter that was subclinically 
infected; and (3) cows that had at least one quarter diagnosed with clinical mastitis. The 
lipopolysaccharide-binding protein (LBP) (A), haptoglobin (B) and serum amyloid A(SAA) (C) 
plasma concentrations were determined by ELISA and reported as mean (± S.E.) concentrations in 
micrograms per milliliter. Different alphabets denote statistically significant (P < 0.05) differences 
between groups. 
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Chapter 4:  Discussion 
         The current study investigated the effects of naturally-occurring subclinical 
intramammary infection and clinical mastitis on the milk and blood concentrations of 
APP’s in dairy cows.  In various surveys, CNS, S. aureus, and Streptococcus spp. have 
been identified as the most frequent bacterial isolates from herd milk samples (Wilson et 
al., 1997; Makovec and Ruegg, 2003).  In milk samples obtained specifically from 
clinical cases of mastitis, CNS, Gram-negative bacilli, S. aureus, and Streptococcus spp. 
have been reported in four surveys to be among the most prevalent bacterial isolates, 
although the absolute rank order of prevalence differs among the surveys (Erskine et al., 
1988; Barkema et al., 1998; Sargeant et al., 1998; Bradley et al., 2007).  In the current 
study, the frequency distribution of the pathogens identified in the milk samples from 
subclinically infected cows and those with clinical mastitis are consistent with these 
previously published surveys (Table 1).  Further, the predominance of the absence of 
bacterial growth in the plated milk samples from quarters with clinical mastitis is 
consistent with a previous report (Bradley et al., 2007).  Thus, the distribution of bacterial 
pathogens isolated from infected quarters in this study was reflective of that observed in 
other herds. 
 Factors such as cyclical bacterial shedding (Sears et al., 1990), milk bacterial 
concentrations below the level of detection (i.e., <50 CFU/ml when plating 20 µL of 
sample), or infection by fastidious pathogens not readily cultured by traditional methods 
(e.g., Mycoplasma bovis), can result in failure to detect an intramammary infection.  
Elevated SCC can serve as an indicator of intramammary infection, and the infection 
status of the gland is one of the most important factors affecting milk SCC (Dohoo and 
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Meek, 1982; Reneau, 1986).  Consistent with this notion, the milk SCC of subclinically 
infected quarters sampled in this study were higher than those of non-infected quarters 
(Fig. 1A).  Several other studies have suggested that a SCC threshold value of 200,000 to 
300,000 cells/ml has diagnostic value for distinguishing between uninfected and infected 
quarters, and consequently, non-inflamed versus inflamed quarters (Dohoo and Meek, 
1982; Reneau, 1986; Schepers et al., 1997; Schukken et al., 2003).  In the current study, 
APP concentrations were analyzed in samples from clinically healthy cows on the basis 
of bacterial growth in plated milk samples, as well as on the basis of an SCC threshold of 
250,000 cells/ml, the latter of which was chosen based on the findings of the previously 
mentioned studies.  In cows with clinical mastitis, the APP concentrations in samples 
from quarters showing clinical signs were compared to those in samples from quarters of 
the same cows that either had a subclinical infection (i.e., positive for bacterial growth on 
plated milk samples) or had SCC <250,000 cell/ml and no bacterial growth.  This 
experimental design allowed for the comparison of APP concentrations from quarters 
showing clinical signs or that were subclinically infected to APP concentrations in 
healthy quarters as defined by the combination of both low SCC and absence of bacterial 
growth.   
 Associations between milk BSA concentrations and infection status of the 
mammary gland have also been previously investigated, and the findings of these studies 
have cast doubt on the utility of BSA as a single diagnostic marker of intramammary 
infection (Verhoeff and Smith, 1981; Mattila et al., 1986; Huszenicza et al., 1997).  The 
findings in the current study that milk BSA concentrations are equivalent in non-infected 
and subclinically infected quarters (Fig. 2A) and higher in quarters with clinical mastitis 
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(Fig. 5B), are consistent with previous reports (Verhoeff and Smith, 1981; Huszenicza et 
al., 1997; Bannerman et al., 2003; Bannerman et al., 2008).  Further, the milk BSA 
concentrations reported here are comparable with those in the aforementioned studies.  
The finding that milk BSA concentrations analyzed on the basis of SCC alone were 
higher in samples with SCC >250,000 cells/ml compared to those with SCC less than this 
amount (Fig. 2B) is consistent with the previous reports establishing a positive 
correlation between milk BSA and SCC (Kitchen et al., 1980; Poutrel et al., 1983). 
   Several reports have suggested that APP’s, such as haptoglobin and SAA, may 
have diagnostic value in identifying cows with subclinical or clinical intramammary 
infections (Eckersall et al., 2001; Nielsen et al., 2004; Gronlund et al., 2005; Hiss et al., 
2007).  Comparison of the temporal onset and duration of increased concentrations of 
LBP to other APP’s has been reported in blood, but not milk.  Relative to other APP’s, 
increases in blood LBP concentrations have been shown to increase earlier, and remain 
elevated for longer, in response to experimental intramammary infection (Bannerman et 
al., 2005; Kauf et al., 2007; Bannerman et al., 2008).  The findings from these studies 
suggest that LBP could be a more sensitive marker of underlying intramammary infection 
because elevated concentrations would be more likely to be detected due to its prolonged 
elevation.  Because clinical signs of mastitis are often readily detected by visual 
observation of the gland and/or milk secretions, the greatest utility for LBP and other 
APP’s would be as diagnostic markers for subclinical intramammary infection.  Results 
from the current study demonstrate that relative to cows with all healthy quarters, blood 
LBP concentrations are elevated in cows with clinical mastitis but not in those with 
subclinical infections (Fig. 6A).  In clinically healthy cows with low SCC, milk LBP 
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concentrations were higher in subclinically infected quarters than in non-infected quarters 
(Fig. 3C).  However, when SCC was not taken into consideration, milk LBP 
concentrations did not differ between subclinically infected and uninfected quarters in 
clinically healthy cows (Fig. 3A).  Interestingly, LBP concentrations were higher than 
those of healthy quarters in the subclinically infected quarters of cows with clinical 
mastitis (Fig. 5C).  This may be due, in part, to the increased availability of LBP that can 
diffuse into these quarters as a result of higher circulating blood concentrations of LBP in 
cows with clinical mastitis (Fig. 6A).  
The current study is the first to report on the milk and blood concentrations of LBP 
in cows with subclinical intramammary infections and cows with naturally-occurring 
clinical mastitis.  The milk (~7 µg/ml) and blood (~23 µg/ml) concentrations of LBP 
identified in the current study in healthy quarters and cows, respectively, are comparable 
to those that have been previously reported (Bannerman et al., 2003; Bannerman et al., 
2004b; Kauf et al., 2007).  Further, in cows with naturally-occurring clinical mastitis, the 
milk (~20 µg /ml) and blood (~113 µg /ml) LBP concentrations detected in this study are 
within the range of those reported during the course of experimentally-induced clinical 
mastitis (Bannerman et al., 2003; Bannerman et al., 2004b; Bannerman et al., 2004c; 
Bannerman et al., 2005). 
For comparison with LBP, the current study also investigated the influence of 
subclinical intramammary infection and clinical mastitis on milk and blood 
concentrations of haptoglobin and SAA, two APPs which have been widely studied as a 
diagnostic marker of udder health (Salonen et al., 1996; Hirvonen et al., 1999; Eckersall 
et al., 2001; Gronlund et al., 2003; Nielsen et al., 2004; Gronlund et al., 2005; Eckersall 
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et al., 2006; Akerstedt et al., 2007; Hiss et al., 2007).  Consistent with these studies, milk 
haptoglobin concentrations were increased in quarters that were subclinically infected or 
showed clinical signs (Fig. 4A and 5D).  Similar to LBP, milk haptoglobin concentrations 
differed between non-infected and infected quarters with low SCC (Fig. 4C).  In contrast 
to LBP, milk haptoglobin concentrations in clinical quarters approached a level that 
statistically differed (P = 0.0666) from those in subclinically infected quarters (Fig. 5D).  
The range of haptoglobin concentrations in milk has been shown to vary greatly across 
studies.  Previously reported mean or median milk haptoglobin concentrations of 3.8 µg 
/ml (Gronlund et al., 2005), 4.4 µg /ml (Hiss et al., 2007), 7.8 µg /ml (Akerstedt et al., 
2007), and 9.7 µg /ml (Gronlund et al., 2003) in subclinically infected quarters are 
comparable with the 4.1 and 7.2 µg /ml concentrations detected in this study in quarters 
that were subclinically infected (Fig. 4A) or had SCC >250,000 cells/ml (Fig. 4B), 
respectively.  Similarly, in quarters with clinical mastitis, the mean milk haptoglobin 
concentration of 79 µg /ml detected in this study is within the range of mean values (40 – 
110 µg /ml) reported by others (Eckersall et al., 2001; Gronlund et al., 2003; Nielsen et 
al., 2004).   
In all but one previous studies (Jacobsen et al., 2005), whole milk was used to 
detect the concentration of amyloid A in secretions from mammary glands, based on the 
assumption that the main part of Amyloid A, an apolipoprotein, will be more likely to be 
associated with the milk fat (Malle et al., 1993; Akerstedt et al., 2007). However, we 
found similar concentrations of amyloid A in whole milk and whey from same udder 
quarters in a preliminary study. In support of our observations, Jacobsen found 
comparable concentrations of amyloid A in different milk fractions including whole milk, 
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skimmed milk and whey (personal communication). Thus, we used whey instead of 
whole milk for the detection of SAA as well as Haptoglobin, LBP and BSA in this study. 
Another difference from all previous studies was that a specific kit dedicated for 
detection of amyloid A in milk was used in our study whereas previous studies used the 
same kit for detection of amyloid A in both blood and milk(Gronlund et al., 2003; 
Pedersen et al., 2003; Nielsen et al., 2004; Akerstedt et al., 2007). However, comparable  
concentrations of milk amyloid A were obtained in a preliminary test with both kits since 
detection antibody from the kit can cross react with different isoforms of amyloid A  in 
blood and milk. Therefore, the relatively low concentrations of milk amyloid A in 
subclinically infected quarters from clinically healthy cows in our study are more likely 
due to factors other than the aforementioned differences.   
In clinically healthy cows, the detection rate of amyloid A in milk samples from 
non-infected quarters 4.4%(15/338) was similar to 2.5% (1/24) for healthy quarters in a 
previous study(Gronlund et al., 2003). The range of amyloid A concentrations in milk 
samples from non-infected quarters (0.23–2.39 ug/ml) is also comparable with the range 
(0.2–0.54 µg/ml) reported by Eckersall (2001) for healthy quarters. However, the 
detection rate (5.4% versus 49% or 54%) and concentration range of amyloid A (0.23–
1.08 µg/ml versus 0.9–151 µg/ml) in milk samples from subclinically-infected quarters 
were much lower than previous findings about clinically healthy quarters or naturally 
subclinically infected quarters (Gronlund et al., 2005; Akerstedt et al., 2007). These 
discrepancies can be partly explained by the different pathogen profile isolated  from 
milk samples from subclinically infected quarters in the previous study, in which 
S.aureus accounted for 46% (13/28), Streptococcus dysgalactiae 36% (10/28), 
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Streptococcus uberis 14% (4/28), CNS 14% (4/28) (Gronlund et al., 2005). The specific 
profile of APPs  induced by each pathogen is somehow mediated by the repertoire of pro-
inflammatory cytokines it can induce in each infection (Baumann et al., 1989; 
Horadagoda et al., 1994; Alsemgeest et al., 1996), which seems to be a pathogen-specific 
case demonstrated by increasing data from experimentally induced IMI (Riollet et al., 
2000; Bannerman et al., 2004a; Bannerman et al., 2004b; Bannerman et al., 2005). 
In clinical mastitis cows, the range of amyloid A concentrations (0.25–129.42 
µg/ml) in quarters with clinical mastitis were consistent with the range (0.2–95 µg/ml) 
reported by Eckersall (2001) for quarters with naturally occurring mastitis. The mean 
(12.73 µg/ml) is also close to 40.2 µg/ml reported by Nielsen (2004) for quarters with 
clinical mastitis considering the remarkable variations in Amyloid A concentrations 
across studies(Eckersall et al., 2001; Nielsen et al., 2004). 
          In contrast to LBP, blood concentrations of haptoglobin were higher in cows with a 
subclinical infection than in those with all healthy quarters (Fig. 6).  Similar to LBP, 
blood concentrations of haptoglobin were higher in cows with clinical mastitis than in 
cows with either a subclinical intramammary infection or all healthy quarters.  In cows 
with clinical mastitis, the mean haptoglobin blood concentration of 1,733 µg /ml detected 
in this study is within the range of 740–1,820 µg /ml reported in previous studies of 
clinical mastitis (Salonen et al., 1996; Hirvonen et al., 1999; Eckersall et al., 2001; 
Gronlund et al., 2003; Nielsen et al., 2004).  
The mean of SAA concentrations (163.14 µg/ml) in blood samples from cows with 
clinical mastitis, is between two median values(13.8 µg/ml & 752 µg/ml) in previous 
studies of cows with naturally clinical mastitis (Eckersall et al., 2001; Nielsen et al., 
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2004). Similarly, the mean of SAA concentration (31.9µg/ml) in blood samples from 
cows with all healthy quarters is between two median values (5.1 µg/ml & 75 µg/ml) 
reported in the above mentioned studies.  
The sharp contrasts between milk and blood samples from clinically healthy cows 
in terms of the detection rates and concentrations of amyloid A indicated that milk 
amyloid A and blood amyloid A might be regulated both locally and systematically using 
different mechanism, as suggested by other studies (Eckersall et al., 2001; McDonald et 
al., 2001; Pedersen et al., 2003; Lehtolainen et al., 2004; Jacobsen et al., 2005; O'Mahony 
et al., 2006; Suojala et al., 2008). In support of our finding, substantial numbers of 
quarters had undetectable levels of MAA in the milk though high level of amyloid A were 
detected in blood in a previous study (O'Mahony et al., 2006). It was possible that 
conditions such as stress and /or extramammary inflammation existed in our study which 
induced a production of acute phase protein in plasma in the absence of intrammary 
infection (Nielsen et al., 2004; Lomborg et al., 2008).  
During clinical mastitis, increased hepatic synthesis of APP’s and inflammation-
induced vascular permeability are most likely to be the predominant events contributing 
to increased milk concentrations of LBP and haptoglobin (Riollet et al., 2000; Bannerman 
et al., 2003; Bannerman et al., 2004c).  However, mammary gland derived origins for 
these proteins cannot be excluded.  Epithelial cells of the respiratory and intestinal tracts 
have been demonstrated to produce LBP in response to pro-inflammatory cytokines that 
are upregulated during mastitis (Vreugdenhil et al., 1999; Dentener et al., 2000; 
Bannerman et al., 2004c).  Thus, one cannot rule out the possibility that the mammary 
epithelium is equally capable of serving as a local source of LBP.  It is known that bovine 
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mammary epithelial cells can synthesize haptoglobin (Thielen et al., 2007).  Moreover, 
haptoglobin is synthesized and stored in the specific granules of neutrophils, and released 
upon their activations (Theilgaard-Monch et al., 2006).  Because milk concentrations of 
neutrophils can approach 5 ×107 cells/ml during mastitis (Bannerman et al., 2004c), one 
cannot exclude these cells as contributing sources of haptoglobin within the inflamed 
gland. 
 To our knowledge, this is the first study to evaluate milk and blood concentrations 
of LBP in cows with naturally-occurring mastitis.  Specifically, this study demonstrated 
that:  (1) LBP concentrations are increased in the milk and blood of quarters and cows, 
respectively, with clinical mastitis; (2) in clinically healthy cows with quarters with low 
SCC, milk concentrations of LBP are increased in quarters with subclinical infections; 
and (3) in clinically healthy cows, milk LBP concentrations are higher in quarters with 
SCC >250,000 cells/ml than in those with lower SCC.  In contrast to the APP haptoglobin, 
blood concentrations of LBP in cows with a subclinical intramammary infection could 
not be differentiated from those of cows with all healthy quarters.  Thus, although 
previous studies have demonstrated a more rapid and prolonged induction of LBP in 
response to experimental intramammary infection than other APP’s, data from this study 
suggest that blood haptoglobin concentrations may serve as a better diagnostic biomarker 







Increased blood concentrations of APP is of marginal value in defining a cow with 
naturally occurring mastitis compared with experimentally induced IMI since various 
extra-mammary gland inflammation can also cause an increase in the blood APP 
concentrations (Saini and Webert, 1991; Nielsen et al.,2004). In contrast, increased 
amyloid A and haptoglobin concentrations are observed earlier in milk than in blood and 
their increase in milk would be a more specific indicator of IMI (Hiss et al., 2004; 
Jacobsen et al., 2005; Suojala et al., 2008). Furthermore, it is a less invasive procedure to 
collect milk samples compared with blood samples. In addition, hepatocyte-derived APP 
and non-hepatocyte derived APP have been suggested to have different immunological 
roles in mice against lung inflammation (Knapp et al., 2006). To this end, additional 
studies are needed to discriminate APPs of different origins and compare their relative 
diagnostic values for the identification of IMI.  
On the other hand, some APPs have similar functions in immune response. Similar 
to LBP, SAA can bind to LPS and haptoglobin can participate in the detoxification of 
LPS (Schroedl et al., 2001; Arredouani et al., 2005). So the concept of APP index which 
takes in account into several APP’s simultaneously might be an alternative to individual 
APP as an indicator of IMI. Further, LBP of different concentrations can exert opposing 
effects with low concentration of LBP related to a pro-inflammatory role and high 
concentration to an anti-inflammatory role. SAA can work as an opsonin for Gram-
negative at normal concentration (Shah et al., 2006). Therefore, a thorough understanding 
of the immunological roles of APPs under various concentrations would allow us to draw 
more relevant conclusions concerning the incidence of mastitis from increased 
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